Company overview
Hydrosome Labs offers ultrafine bubble (UFB) technology, branded as Hydrosome H2O, that enhances precision fermentation by improving nutrient and gas delivery to cells. This results in 2X faster cell doubling, 25% less fermentation time, and 2X higher biomass yields without new infrastructure. Applications span pharmaceuticals, biopharma, industrial enzymes, and biomanufacturing, addressing capacity bottlenecks.
Hydrosome is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include ultrafine bubbles, precision fermentation, hydrosome h2o, biomanufacturing, cell culture enhancement.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Hydrosome include Cell Culture — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://hydrosomelabs.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- ultrafine bubbles, precision fermentation, hydrosome h2o, biomanufacturing, cell culture enhancement
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What capabilities does Hydrosome Labs' technology provide for precision fermentation?
- Hydrosome H2O uses ultrafine bubbles to enhance nutrient and gas transfer, achieving 2X faster cell doubling, 25% shorter fermentation time, and 2X higher peak biomass in the same tanks.
- What industries and applications does Hydrosome Labs serve?
- The technology supports pharmaceuticals, biopharma, industrial enzymes, biofuels, food ingredients, brewing, cellular agriculture, and mammalian cell culture via aerobic/anaerobic fermentation.
- Is Hydrosome Labs' technology chemical-free and scalable?
- Yes, it is a natural, chemical-free process using hydrodynamic cavitation, stable for at least two years, requiring no additional capital investment or new equipment.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
